NRIX

Nurix Therapeutics, Inc. is a San Francisco-based biopharmaceutical company dedicated to revolutionizing cancer and immune disorder treatments through the development of innovative small molecule therapies. Leveraging its proprietary drug discovery platform, the company focuses on targeted protein degradation, a method that opens new avenues for improving patient outcomes in oncology and immunology. With a robust pipeline of candidates and a commitment to advancing next-generation therapeutics, Nurix presents a compelling investment opportunity for institutional investors seeking to engage in transformative health solutions.